BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18591387)

  • 1. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
    Wenzlau JM; Liu Y; Yu L; Moua O; Fowler KT; Rangasamy S; Walters J; Eisenbarth GS; Davidson HW; Hutton JC
    Diabetes; 2008 Oct; 57(10):2693-7. PubMed ID: 18591387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
    Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
    Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
    Kawasaki E; Uga M; Nakamura K; Kuriya G; Satoh T; Fujishima K; Ozaki M; Abiru N; Yamasaki H; Wenzlau JM; Davidson HW; Hutton JC; Eguchi K
    Diabetologia; 2008 Dec; 51(12):2299-302. PubMed ID: 18850084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study.
    Delli AJ; Vaziri-Sani F; Lindblad B; Elding-Larsson H; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Örtqvist E; Groop L; Bondinas GP; Papadopoulos GK; Lernmark Å;
    Diabetes; 2012 Oct; 61(10):2556-64. PubMed ID: 22787139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
    Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
    Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
    Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
    Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
    Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
    Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.
    Howson JM; Krause S; Stevens H; Smyth DJ; Wenzlau JM; Bonifacio E; Hutton J; Ziegler AG; Todd JA; Achenbach P
    Diabetologia; 2012 Jul; 55(7):1978-84. PubMed ID: 22526605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
    Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
    Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kobayashi M; Kuwahara H; Abiru N; Yamasaki H; Matsuura N; Miura J; Uchigata Y; Eguchi K
    Diabetes Metab Res Rev; 2011 Nov; 27(8):895-8. PubMed ID: 22069281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
    Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
    J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kobayashi M; Kuwahara H; Abiru N; Yamasaki H; Matsuura N; Miura J; Uchigata Y; Eguchi K
    Clin Immunol; 2011 Feb; 138(2):146-53. PubMed ID: 21067978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between ZnT8Ab, the SLC30A8 gene and disease progression in children with newly diagnosed type 1 diabetes.
    Nielsen LB; Vaziri-Sani F; Pörksen S; Andersen ML; Svensson J; Bergholdt R; Pociot F; Hougaard P; de Beaufort C; Castaño L; Mortensen HB; Lernmark A; Hansen L;
    Autoimmunity; 2011 Dec; 44(8):616-23. PubMed ID: 21604969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.
    Andersen ML; Vaziri-Sani F; Delli A; Pörksen S; Jacobssen E; Thomsen J; Svensson J; Steen Petersen J; Hansen L; Lernmark A; Mortensen HB; Nielsen LB
    Pediatr Diabetes; 2012 Sep; 13(6):454-62. PubMed ID: 22686132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.